A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

• 

• 
  • The Journal
  • Editor-In-Chief
  • Editorial Calendar
  • Submissions
  • Advertising
  • Permissions & Reprints
  • Privacy Policy

• 
  • Subscribe
  • Renew
  • Prices
  • Free Sample

• 
  • View Shopping Cart
  • Back Issues
  • Articles
  • Library Archives
  • Compounding Theme Archives
  • Other Products

• 
  • Supplemental Content and Errata
  • Training and Education
  • IJPC-PCAB SOP Matrix
  • USP GAP Analysis
  • Compounders' Network List
  • Patient Information
  • Videos
  • Compounders' Resource Directory

• 

• 

PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing

Author(s):  Allen Loyd V Jr

Issue:  Mar/Apr 2018 - Volume 22, Number 2
View All Articles in Issue

Abstract:  

Related Keywords: Loyd V. Allen Jr., PhD, RPh, DQSA, U.S. House of Representatives Energy and Commerce Committee, Subcommittee on Health, Examining Implementation of the Compounding Quality Act, U.S. Food and Drug Administration, FDA, pharmacy compounding oversight and regulation, office-use compounding, Pharmacy Compounding Advisory Committee, PCAC, dietary supplements, CGMP standards, Guidance for Industry documents, HR2871

Related Categories: LEGAL, PROFESSIONAL ISSUES

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details)	Author	Issue	Page	View/Buy
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing	Allen Loyd V Jr	Mar/Apr 2018	92	Buy
IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing	Blankenship Cynthia	Mar/Apr 2018	125-126	Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines	Allen Loyd V Jr	Jul/Aug 2016	351	View Sample
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs	Allen Loyd V Jr	Nov/Dec 2015	487-488	Buy
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1	Allen Loyd V Jr	Sep/Oct 2015	389-390	Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs	Allen Loyd V Jr	Sep/Oct 2017	356	Buy
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies	Yoch Doug	Mar/Apr 2017	95-102	Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances	Miller David G	Jul/Aug 2015	303-305	Buy
Applying Quality of Design Concepts to Pharmacy Compounding	Timko Robert J	Nov/Dec 2015	453-463	Buy
Standing Together Fixing the Drug Quality and Security Act	Miller David G	Mar/Apr 2015	104-106	Buy